↓ Skip to main content

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma

Overview of attention for article published in New England Journal of Medicine, September 2018

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Readers on

mendeley
325 Mendeley